X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (20459) 20459
Newsletter (143) 143
Magazine Article (115) 115
Newspaper Article (66) 66
Transcript (12) 12
Book Chapter (10) 10
Dissertation (3) 3
Publication (3) 3
Streaming Video (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (18746) 18746
male (12473) 12473
prednisone - administration & dosage (11776) 11776
female (11376) 11376
middle aged (8561) 8561
adult (8135) 8135
aged (6148) 6148
antineoplastic combined chemotherapy protocols - therapeutic use (5933) 5933
prednisone - therapeutic use (5801) 5801
vincristine - administration & dosage (5382) 5382
cyclophosphamide - administration & dosage (5070) 5070
prednisone (5052) 5052
treatment outcome (4169) 4169
doxorubicin - administration & dosage (4008) 4008
oncology (3873) 3873
adolescent (3734) 3734
drug therapy, combination (2778) 2778
child (2714) 2714
chemotherapy (2701) 2701
antineoplastic combined chemotherapy protocols - administration & dosage (2608) 2608
hematology (2579) 2579
prednisone - adverse effects (2354) 2354
therapy (2179) 2179
prognosis (2167) 2167
follow-up studies (2141) 2141
corticosteroids (2117) 2117
drug administration schedule (1999) 1999
aged, 80 and over (1952) 1952
retrospective studies (1927) 1927
time factors (1901) 1901
antineoplastic combined chemotherapy protocols - adverse effects (1806) 1806
combined modality therapy (1713) 1713
cancer (1668) 1668
child, preschool (1668) 1668
care and treatment (1560) 1560
remission induction (1554) 1554
methotrexate - administration & dosage (1503) 1503
administration, oral (1489) 1489
rituximab (1480) 1480
cyclophosphamide - therapeutic use (1284) 1284
glucocorticoids - administration & dosage (1274) 1274
disease-free survival (1261) 1261
prospective studies (1250) 1250
medicine, general & internal (1241) 1241
procarbazine - administration & dosage (1196) 1196
recurrence (1192) 1192
lymphoma, non-hodgkin - drug therapy (1191) 1191
bleomycin - administration & dosage (1186) 1186
dose-response relationship, drug (1183) 1183
prostate cancer (1172) 1172
immunosuppressive agents - therapeutic use (1171) 1171
survival (1167) 1167
drug therapy (1160) 1160
survival rate (1134) 1134
lymphoma, large b-cell, diffuse - drug therapy (1114) 1114
transplantation (1105) 1105
survival analysis (1103) 1103
cyclophosphamide (1101) 1101
neoplasm staging (1093) 1093
glucocorticoids - therapeutic use (1083) 1083
hodgkin disease - drug therapy (1061) 1061
animals (1039) 1039
risk factors (1036) 1036
vincristine - therapeutic use (1021) 1021
anti-inflammatory agents - administration & dosage (977) 977
anti-inflammatory agents - therapeutic use (975) 975
pediatrics (974) 974
medicine & public health (968) 968
cyclophosphamide - adverse effects (962) 962
immunosuppressive agents - administration & dosage (954) 954
vincristine - adverse effects (940) 940
infant (926) 926
disease (906) 906
urology & nephrology (901) 901
docetaxel (900) 900
trial (895) 895
etoposide - administration & dosage (890) 890
clinical trials as topic (887) 887
biopsy (881) 881
children (865) 865
research (859) 859
multiple myeloma - drug therapy (841) 841
dosage and administration (837) 837
young adult (835) 835
lymphomas (832) 832
antineoplastic agents - therapeutic use (828) 828
antineoplastic agents - administration & dosage (818) 818
immunology (817) 817
patients (804) 804
steroids (789) 789
analysis (784) 784
rheumatology (782) 782
surgery (767) 767
doxorubicin - therapeutic use (754) 754
mechlorethamine - administration & dosage (747) 747
cytarabine - administration & dosage (740) 740
doxorubicin - adverse effects (738) 738
prostatic neoplasms - drug therapy (729) 729
health aspects (721) 721
diagnosis, differential (720) 720
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (18456) 18456
German (522) 522
French (416) 416
Spanish (352) 352
Japanese (345) 345
Polish (303) 303
Chinese (182) 182
Italian (148) 148
Russian (100) 100
Dutch (42) 42
Czech (38) 38
Portuguese (27) 27
Danish (25) 25
Romanian (22) 22
Hungarian (17) 17
Hebrew (15) 15
Norwegian (8) 8
Serbian (7) 7
Finnish (5) 5
Bulgarian (4) 4
Slovak (4) 4
Croatian (3) 3
Swedish (3) 3
Bosnian (1) 1
Korean (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England journal of medicine, ISSN 1533-4406, 2007, Volume 357, Issue 25, pp. 2562 - 2575
This study examines the toxicity of immunosuppressive regimens in renal-transplant recipients. A regimen containing mycophenolate mofetil, daclizumab, low-dose... 
MULTICENTER TRIAL | MEDICINE, GENERAL & INTERNAL | CYCLOSPORINE MICROEMULSION | EFFICACY | KIDNEY-TRANSPLANTATION | IMMUNOSUPPRESSION | ALLOGRAFT RECIPIENTS | TACROLIMUS | MYCOPHENOLATE-MOFETIL | SIROLIMUS | NEPHROTOXICITY | Humans | Immunosuppressive Agents - therapeutic use | Middle Aged | Male | Adrenal Cortex Hormones - therapeutic use | Enzyme Inhibitors - administration & dosage | Antibodies, Monoclonal, Humanized | Calcineurin Inhibitors | Treatment Failure | Adult | Diabetes Mellitus - etiology | Female | Drug Therapy, Combination | Mycophenolic Acid - administration & dosage | Immunosuppressive Agents - administration & dosage | Sirolimus - adverse effects | Tacrolimus - administration & dosage | Prednisone - administration & dosage | Glomerular Filtration Rate | Graft Rejection - prevention & control | Kaplan-Meier Estimate | Kidney Transplantation | Immunoglobulin G - administration & dosage | Opportunistic Infections | Sirolimus - administration & dosage | Mycophenolic Acid - analogs & derivatives | Antibodies, Monoclonal - administration & dosage | Cyclosporine - administration & dosage | Immunosuppressive Agents - adverse effects | Aged | Adrenal Cortex Hormones - administration & dosage | Transplantation | Corticosteroids | Kidneys | Research | Health aspects | Immunosuppressive agents | Medical research | Immunology | Inhibitor drugs | Transplants & implants | Toxicity | Inhibidors enzimàtics | Posologia | Ús terapèutic | Corticosteroides | Rebuig (Biologia) | Posology | Therapeutic use | Immunosupressive agents | Graft rejection | Trasplantament renal | Enzyme inhibitors | Adrenocortical hormones | Immunosupressors | Kidney transplantation | Tacrolimus: administration & dosage | Medical and Health Sciences | Graft Rejection: prevention & control | Immunoglobulin G: administration & dosage | Medicin och hälsovetenskap | Mycophenolic Acid: administration & dosage | Antibodies | Klinisk medicin | Monoclonal: administration & dosage | Prednisone: administration & dosage | Adrenal Cortex Hormones: administration & dosage | Immunosuppressive Agents: administration & dosage | Mycophenolic Acid: analogs & derivatives | Sirolimus: administration & dosage | Cyclosporine: administration & dosage | Calcineurin: antagonists & inhibitors | Diabetes Mellitus: etiology | Urologi och njurmedicin | Sirolimus: adverse effects | Adrenal Cortex Hormones: therapeutic use | Enzyme Inhibitors: administration & dosage | Immunosuppressive Agents: adverse effects | Clinical Medicine | Immunosuppressive Agents: therapeutic use | Urology and Nephrology
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2016, Volume 34, Issue 17, pp. 2020 - 2027
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2013, Volume 368, Issue 15, pp. 1408 - 1416
A dose-intense infusional chemotherapy program plus rituximab had a high degree of efficacy in patients with primary mediastinal B-cell lymphoma, which is... 
MEDICINE, GENERAL & INTERNAL | AMPLIFICATION | MANAGEMENT | EFFICACY | DOXORUBICIN | SCLEROSIS | CLASSICAL HODGKIN LYMPHOMA | RADIOTHERAPY | EXPRESSION | GERMINAL-CENTER | CHEMOTHERAPY | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Follow-Up Studies | Humans | Middle Aged | Antibodies, Monoclonal, Murine-Derived - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Cyclophosphamide - adverse effects | Filgrastim | Dose-Response Relationship, Drug | Young Adult | Vincristine - administration & dosage | Adult | Female | Retrospective Studies | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Etoposide - adverse effects | Lymphoma, Large B-Cell, Diffuse - drug therapy | Prednisone - adverse effects | Kaplan-Meier Estimate | Rituximab | Stroke Volume - drug effects | Etoposide - administration & dosage | Recombinant Proteins - administration & dosage | Disease-Free Survival | Vincristine - adverse effects | Aged | Antibodies, Monoclonal, Murine-Derived - adverse effects | Doxorubicin - adverse effects | Granulocyte Colony-Stimulating Factor - administration & dosage | Drugs | Dose-response relationship (Biochemistry) | Usage | Cyclophosphamide | Patient outcomes | Dosage and administration | Lymphomas | Product/Service Evaluations | Drug therapy, Combination | Drug therapy | Doxorubicin | Medical research | Nuclear magnetic resonance--NMR | Disease | Review boards | Genes | Etoposide | Prednisone | Radiation therapy | Kinases | Vincristine | Patients | Morbidity | Chemotherapy | Lymphocytes B | Remission | Mutation | Hodgkin's disease | B-cell lymphoma
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 03/2010, Volume 362, Issue 11, pp. 975 - 985
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2017, Volume 377, Issue 4, pp. 338 - 351
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2016, Volume 387, Issue 10036, pp. 2402 - 2411
Summary Background Short intensive chemotherapy is the standard of care for adult patients with Burkitt's leukaemia or lymphoma. Findings from single-arm... 
Internal Medicine | MEDICINE, GENERAL & INTERNAL | CODOX-M/IVAC | CLEAVED-CELL LYMPHOMA | THERAPY | MULTIAGENT CHEMOTHERAPY | ADOLESCENTS | PLUS RITUXIMAB | NON-HODGKIN-LYMPHOMA | SURVIVAL RATE | LEUKEMIA | CHILDREN | Cyclophosphamide - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Injections, Intravenous | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Patient Selection | Burkitt Lymphoma - pathology | Hydrocortisone - administration & dosage | Vincristine - administration & dosage | Adult | Female | France | Odds Ratio | Burkitt Lymphoma - drug therapy | Doxorubicin - administration & dosage | Prednisone - administration & dosage | Drug Administration Schedule | Biomarkers, Tumor - analysis | Proportional Hazards Models | Treatment Outcome | Burkitt Lymphoma - diagnosis | Burkitt Lymphoma - chemistry | Cytarabine - administration & dosage | Rituximab - administration & dosage | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Methotrexate - administration & dosage | Aged | Bone Marrow Neoplasms - drug therapy | Neoplasm Staging | Central Nervous System Neoplasms - drug therapy | Methylprednisolone - administration & dosage | Chemotherapy | Leukemia | Lymphomas | Adults | Epidemiology | Biometry | Cancer | Survival analysis | Biomedical research | Dehydrogenases | Medical prognosis | Clinical trials
Journal Article
Journal of clinical oncology, ISSN 1527-7755, 2010, Volume 28, Issue 27, pp. 4199 - 4206
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 08/2015, Volume 2015, Issue 8, p. CD001430
Background Optic neuritis is an inflammatory disease of the optic nerve. It usually presents with an abrupt loss of vision and recovery of vision is almost... 
Acute Disease | Dexamethasone | Injections, Intravenous | Glucocorticoids | Administration, Oral | Optic Neuritis | Prednisone | Methylprednisolone | Visual Acuity | Randomized Controlled Trials as Topic | Optic nerve disease | Anti‐Inflammatory Agents | Eyes & vision | Medicine General & Introductory Medical Sciences | Contrast Sensitivity | TREATMENT-TRIAL | Humans | Male | FOLLOW-UP | RECOVERY | MEDICINE, GENERAL & INTERNAL | HIGH-DOSE METHYLPREDNISOLONE | MULTIPLE-SCLEROSIS | Female | Anti-Inflammatory Agents [administration & dosage; therapeutic use] | VISUAL-FIELD PROFILE | Prednisone [administration & dosage; therapeutic use] | Methylprednisolone [administration & dosage; therapeutic use] | Dexamethasone [administration & dosage; therapeutic use] | Contrast Sensitivity [drug effects] | Optic Neuritis [drug therapy] | INJECTION | EXPERIENCE | Visual Acuity [drug effects] | Glucocorticoids [administration & dosage; therapeutic use] | FUNCTION QUESTIONNAIRE | Glucocorticoids - administration & dosage | Glucocorticoids - therapeutic use | Prednisone - administration & dosage | Dexamethasone - administration & dosage | Methylprednisolone - therapeutic use | Dexamethasone - therapeutic use | Visual Acuity - drug effects | Optic Neuritis - drug therapy | Contrast Sensitivity - drug effects | Anti-Inflammatory Agents - therapeutic use | Anti-Inflammatory Agents - administration & dosage | Prednisone - therapeutic use | Methylprednisolone - administration & dosage
Journal Article